Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Autoimmune Disorders

Free Subscription 06.10.2025 2 Ann Neurol 5 BMC Neurol 1 Brain 1 Intern Med 2 J Autoimmun 2 J Immunol 2 J Nephrol 1 J Neuroimmunol 3 J Neurol 1 J Pediatr Endocrinol Metab 5 J Rheumatol 4 Kidney Int 1 Lancet 1 Lancet Neurol 3 Mult Scler 5 Neurology 2 PLoS One 2 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. GHEZZI L, Kosa P, Greenwood M, Alvarez E, et al
   From Diagnosis to Disease Staging: Multisite Validation of Cerebrospinal Fluid Molecular Tests in Multiple Sclerosis.
   Ann Neurol. 2025 Oct 3. doi: 10.1002/ana.78047.
   PubMed         Abstract available
   
   
2. BREVILLE G, Benkhoucha M, Rezk A, Tran NL, et al
   Pro-Inflammatory c-Met(+) CD4 T Cells in Multiple Sclerosis.
   Ann Neurol. 2025 Sep 26. doi: 10.1002/ana.78035.
   PubMed         Abstract available
   
   

   
   BMC Neurol

3. LAI J, Zhang X, Wang Y, Cheng Y, et al
   Autoimmune nodopathy with anti-NF186 antibodies following SARS-CoV-2 infection: a case report.
   BMC Neurol. 2025;25:405.
   PubMed         Abstract available
   
   
4. HU BQ, Wu SX, Tong QW, Ye H, et al
   Efgartigimod for treating Guillain-Barre syndrome with poor response to intravenous immunoglobulin: a case report.
   BMC Neurol. 2025;25:403.
   PubMed         Abstract available
   
   
5. LUO YL, Chen LY, Xu ZC, Xu P, et al
   When MOGAD mimics MS: diagnostic and therapeutic insights from a unique CNS demyelinating case.
   BMC Neurol. 2025;25:398.
   PubMed         Abstract available
   
   
6. YAN J, Choi K, Fu P, Li Y, et al
   Perioperative Efgartigimod treatment for acute myasthenia gravis exacerbation with retroperitoneal mass: a case report.
   BMC Neurol. 2025;25:384.
   PubMed         Abstract available
   
   
7. WEI X, Liu G, Wang D, Jie S, et al
   Implications of coexisting neural antibodies with glial fibrillary acidic protein autoimmunity: a single center retrospective cohort study.
   BMC Neurol. 2025;25:401.
   PubMed         Abstract available
   
   

   
   Brain

8. ASHIKAWA Y, Itokazu T, Yamashita T
   Astrocyte regeneration via FGF8-DBX1 signalling facilitates recovery in neuromyelitis optica rats.
   Brain. 2025;148:3763-3777.
   PubMed         Abstract available
   
   

   
   Intern Med

9. SAITO S, Chikada A, Tsutsumi S, Hotta Y, et al
   Severe Recurrent Guillain-Barre Syndrome with Antibodies against Ganglioside Complexes Related to GQ1b and GD1b.
   Intern Med. 2025 Oct 2. doi: 10.2169/internalmedicine.6096.
   PubMed         Abstract available
   
   

   
   J Autoimmun

10. FUKUI S, Michitsuji T, Endo Y, Nishino A, et al
    Treatment outcomes stratified by interferon profile and autoantibodies in rheumatoid arthritis.
    J Autoimmun. 2025;157:103490.
    PubMed         Abstract available
    
    
11. WANG Y, Yang S, Yu Y, Xia P, et al
    Preliminary safety and efficacy of relmacabtagene autoleucel (relma-cel) in adults with moderately to severely active systemic lupus erythematosus: a phase I dose-escalation study.
    J Autoimmun. 2025;157:103489.
    PubMed         Abstract available
    
    

    
    J Immunol

12. ZIPFEL PF, Heidenreich K
    The 4 functional segments of Factor H: Role in physiological target recognition and contribution to disease.
    J Immunol. 2025;214:2150-2164.
    PubMed         Abstract available
    
    
13. LIU F, Wawersik S, Tomlinson S, Thurman JM, et al
    Tissue-targeted regulators of complement for amelioration of human disease: rationale and novel therapeutic strategies.
    J Immunol. 2025;214:2138-2149.
    PubMed         Abstract available
    
    

    
    J Nephrol

14. WATANABE-KUSUNOKI K, Nakazawa D, Ohigashi H, Tsuji T, et al
    Membranous nephropathy preceding Bing-Neel syndrome: successful treatment with tirabrutinib.
    J Nephrol. 2025 Sep 26. doi: 10.1007/s40620-025-02401.
    PubMed         Abstract available
    
    
15. BENVENUTI F, Proglio M, Rigno M, Sorbo D, et al
    Iptacopan/LNP023 and rituximab as rescue therapy in a patient with systemic lupus erythematosus-associated atypical haemolytic uraemic syndrome.
    J Nephrol. 2025 Sep 25. doi: 10.1007/s40620-025-02425.
    PubMed         Abstract available
    
    

    
    J Neuroimmunol

16. GOUZOUASIS V, Tsifintaris M, Tastsoglou S, Markoglou N, et al
    Epstein-Barr virus reactivation is associated with altered immune cell profiles in peripheral blood and cerebrospinal fluid of treatment-naive multiple sclerosis patients.
    J Neuroimmunol. 2025;409:578758.
    PubMed         Abstract available
    
    

    
    J Neurol

17. KO KY, Kazzi C, Seery N, Griffith S, et al
    Subjective psychiatric symptoms in post-acute autoimmune encephalitis: findings from the Australian autoimmune encephalitis consortium.
    J Neurol. 2025;272:665.
    PubMed         Abstract available
    
    
18. WAGSHUL ME, Nayak S, Foley FW, Motl RW, et al
    Grey matter atrophy patterns of mobility shared across older adults with and without multiple sclerosis.
    J Neurol. 2025;272:656.
    PubMed         Abstract available
    
    
19. YANG X, Jia Z, Lian X, Zhang R, et al
    Ofatumumab treatment in patients with neuromyelitis optica spectrum disorder: a retrospective multicenter cohort study.
    J Neurol. 2025;272:655.
    PubMed         Abstract available
    
    

    
    J Pediatr Endocrinol Metab

20. PESCINI A, Tyutyusheva N, Indolfi G, Rubino C, et al
    Noonan syndrome and autoimmune hepatitis: patient report and literature review.
    J Pediatr Endocrinol Metab. 2025 Sep 29. doi: 10.1515/jpem-2025-0301.
    PubMed         Abstract available
    
    

    
    J Rheumatol

21. RUBINSTEIN TB, Touma Z, Blanco I, Knight AM, et al
    Improving Mental Health Care for People With Systemic Lupus Erythematosus: Time to Take Action.
    J Rheumatol. 2025 Oct 1:jrheum.2025-0922. doi: 10.3899/jrheum.2025-0922.
    PubMed        
    
    
22. MAYO-JUANATEY A, Castaneda S, Calvo-Rio V, Garijo-Bufort M, et al
    Anifrolumab in Systemic Lupus Erythematosus With Severe Hematological Manifestations: A Spanish Multicenter Study.
    J Rheumatol. 2025 Oct 1:jrheum.2025-0658. doi: 10.3899/jrheum.2025-0658.
    PubMed        
    
    
23. LOPEZ-MARTINEZ J, Esplugues Clos J, Fernandez-Valmana A, Feijoo-Masso C, et al
    Renal AA Amyloidosis Associated With Systemic Lupus Erythematosus Treated With Anakinra.
    J Rheumatol. 2025 Oct 1:jrheum.2025-0431. doi: 10.3899/jrheum.2025-0431.
    PubMed        
    
    
24. PONGTARAKULPANIT N, Bishnoi A, Chandra T, Dzanko S, et al
    Quantifying Cutaneous Dermatomyositis: A Novel 3D Image-based Approach.
    J Rheumatol. 2025 Oct 1:jrheum.2025-0537. doi: 10.3899/jrheum.2025-0537.
    PubMed         Abstract available
    
    
25. SRINIVASALU H, Beukelman T, Dennos A, Chen A, et al
    Juvenile Psoriatic Arthritis Inception Cohort in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry: Characteristics and Early Disease Outcomes.
    J Rheumatol. 2025;52:1013-1020.
    PubMed         Abstract available
    
    

    
    Kidney Int

26. ZAHNER G, Dehde S, Seifert L, Huang M, et al
    Patient anti-PLA2R1 autoantibodies cause membranous nephropathy in human PLA2R1 transgenic mice.
    Kidney Int. 2025 Sep 29:S0085-2538(25)00757-4. doi: 10.1016/j.kint.2025.
    PubMed         Abstract available
    
    
27. JAVAUGUE V, Pascal V, Nasr SH, Bender S, et al
    Revisiting proliferative glomerulonephritis with monoclonal immunoglobulin deposits through immunoglobulin repertoire sequencing.
    Kidney Int. 2025 Sep 24:S0085-2538(25)00751-3. doi: 10.1016/j.kint.2025.
    PubMed         Abstract available
    
    
28. LAZARETH H, Lenoir O, Garo F, Rocha A, et al
    Mineralocorticoid receptor inhibition in parietal epithelial cells prevents focal segmental glomerulosclerosis and crescentic glomerulonephritis.
    Kidney Int. 2025 Sep 24:S0085-2538(25)00748-3. doi: 10.1016/j.kint.2025.
    PubMed         Abstract available
    
    
29. NOVAK L, Hall SD, Cutter G, Gurganus GL, et al
    Kidney injury and colocalization of complement C3, IgA, and IgG in glomerular immune-complex deposits of patients with IgA nephropathy or IgA vasculitis with nephritis.
    Kidney Int. 2025 Sep 22:S0085-2538(25)00749-5. doi: 10.1016/j.kint.2025.
    PubMed         Abstract available
    
    

    
    Lancet

30. MATHIEU C, Wych J, Hendriks AEJ, Van Ryckeghem L, et al
    Minimum effective low dose of antithymocyte globulin in people aged 5-25 years with recent-onset stage 3 type 1 diabetes (MELD-ATG): a phase 2, multicentre, double-blind, randomised, placebo-controlled, adaptive dose-ranging trial.
    Lancet. 2025 Sep 18:S0140-6736(25)01674-5. doi: 10.1016/S0140-6736(25)01674.
    PubMed         Abstract available
    
    

    
    Lancet Neurol

31. CHITNIS T, Magliozzi R, Abdelhak A, Kuhle J, et al
    Blood and CSF biomarkers for multiple sclerosis: emerging clinical applications.
    Lancet Neurol. 2025 Sep 24:S1474-4422(25)00249.
    PubMed         Abstract available
    
    

    
    Mult Scler

32. RIVIER CA, Xu L, Clocchiatti-Tuozzo S, Zhao H, et al
    Differential results of genetic risk scoring for multiple sclerosis in European and African American populations.
    Mult Scler. 2025 Sep 24:13524585251377607. doi: 10.1177/13524585251377607.
    PubMed         Abstract available
    
    
33. LEAVITT VM, Simani L, Koch M, Morrow SA, et al
    The language and memory test: A brief multidomain digital cognitive measure for multiple sclerosis.
    Mult Scler. 2025 Sep 25:13524585251366096. doi: 10.1177/13524585251366096.
    PubMed         Abstract available
    
    
34. GRAY-RONCAL K, Appiah MJ, Zorn K, Smith KC, et al
    Increased contact with clinical trial participants may improve confirmed multiple sclerosis relapse detection.
    Mult Scler. 2025 Sep 25:13524585251373002. doi: 10.1177/13524585251373002.
    PubMed         Abstract available
    
    

    
    Neurology

35. LINDROOS JLV, Bjork MH, Cohen JM, Danielsson KC, et al
    Obstetric and Neonatal Outcomes in Patients With Maternal Myasthenia Gravis: A Nationwide Cohort Study.
    Neurology. 2025;105:e214139.
    PubMed         Abstract available
    
    
36. BSTEH G, Hegen H, Krajnc N, Fottinger F, et al
    Association Between Retinal Layer Atrophy With Clinical and Radiologic Progression in People With Relapsing Multiple Sclerosis.
    Neurology. 2025;105:e214069.
    PubMed         Abstract available
    
    
37. OVED K, Denkberg G, Pinzur L, Chroni E, et al
    Subunit-Specific Immunodominance in Clinically Distinct Populations With AChR+ Myasthenia Gravis: A Multiparametric Cross-Sectional Analysis.
    Neurology. 2025;105:e214150.
    PubMed         Abstract available
    
    
38. SAHI N, Ciccarelli O, Houlden H, Chard DT, et al
    Unlocking Multiple Sclerosis Genetics: From Susceptibility to Severity.
    Neurology. 2025;105:e214141.
    PubMed         Abstract available
    
    
39. KRENN M, Wagner M, Schuller H, Pugna I, et al
    Screening for Congenital Myasthenic Syndromes in Adults With Seronegative Myasthenia Gravis Using Next-Generation Sequencing.
    Neurology. 2025;105:e214177.
    PubMed         Abstract available
    
    

    
    PLoS One

40. NAKHOUL L, Nakhoul T, Abi Azar M, Harb F, et al
    The efficacy of DPP IV inhibitors as adjunct therapy for patients with auto-immune Diabetes: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0332191.
    PubMed         Abstract available
    
    
41. SURENDRANATH A, Damani R, Muddasani A, Gupta AK, et al
    Comparing Guillain-Barre syndrome outcomes between rural and urban hospitals in the United States: A retrospective cohort study.
    PLoS One. 2025;20:e0333403.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

42. TRSELIC T, Pelo N, Martin de Fremont G, Iyer VS, et al
    Autoimmunity-associated DIORA1 binds the MRCK family of serine/threonine kinases and controls cell motility.
    Proc Natl Acad Sci U S A. 2025;122:e2426917122.
    PubMed         Abstract available
    
    
43. 
    Correction for Zhao et al., Blood-labyrinth barrier damage mediated by granzymes from cytotoxic lymphocytes results in hearing loss in systemic lupus erythematosus.
    Proc Natl Acad Sci U S A. 2025;122:e2525323122.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Autoimmune Disorders is free of charge.